Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, Marguerite B. McDonald, MD, FACS, discusses the use of DefEYE’s Biovance 3L Ocular decellularized basement membrane for the treatment of neurotrophic keratitis.
“It works,” McDonald, of OCLI Vision, told Healio. “It’s comfortable. More and more of my peers are using it. I certainly use it as a first-line treatment for [neurotrophic keratitis] starting at stage one and above.”

